NCT03896009Phase 3Completed

Maximizing Outcomes in Treating Acute Migraine

Study sponsor: Axsome Therapeutics, Inc. · AXSM

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2019-12-10Actual
Enrollment · participants1594Actual
Source updated2023-08-24Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.